176 related articles for article (PubMed ID: 26186205)
21. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.
Bayadsi H; Nylén C; Sandström M; Angelsten J; Sund M; Hennings J
Langenbecks Arch Surg; 2023 Apr; 408(1):162. PubMed ID: 37099203
[TBL] [Abstract][Full Text] [Related]
23. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS
World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807
[TBL] [Abstract][Full Text] [Related]
24. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
25. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
[TBL] [Abstract][Full Text] [Related]
26. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
27. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
[TBL] [Abstract][Full Text] [Related]
29. Histopathological Characteristics of N1b Papillary Thyroid Carcinoma are Associated with Risk of Recurrence.
Carmel Neiderman NN; Duek I; Kuzmenko B; Ringel B; Warshavsky A; Muhanna N; Horowitz G; Fliss DM
World J Surg; 2022 Aug; 46(8):1917-1925. PubMed ID: 35543736
[TBL] [Abstract][Full Text] [Related]
30. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
[TBL] [Abstract][Full Text] [Related]
31. Association of patient age with high-risk pathologic features in papillary thyroid cancer.
Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT
J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122
[TBL] [Abstract][Full Text] [Related]
32. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
33. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB
Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731
[TBL] [Abstract][Full Text] [Related]
34. Transaxillary robotic modified radical neck dissection: a 5-year assessment of operative and oncologic outcomes.
Kim MJ; Lee J; Lee SG; Choi JB; Kim TH; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jo YS; Chung WY
Surg Endosc; 2017 Apr; 31(4):1599-1606. PubMed ID: 27572060
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis.
Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Lee BJ
Ann Surg Oncol; 2011 Nov; 18(12):3486-92. PubMed ID: 21553141
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for persistent disease in papillary thyroid carcinoma with lymph node metastasis.
Oral A; Yazici B; Akgün A; Hassoy H; Özcan Z
Nucl Med Commun; 2016 Jul; 37(7):721-6. PubMed ID: 26967062
[TBL] [Abstract][Full Text] [Related]
37. Thyroglossal Duct Cyst Carcinomas: A Clinicopathologic Series of 22 Cases with Staging Recommendations.
Thompson LDR; Herrera HB; Lau SK
Head Neck Pathol; 2017 Jun; 11(2):175-185. PubMed ID: 27704385
[TBL] [Abstract][Full Text] [Related]
38. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
39. Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):253-260. PubMed ID: 27762727
[TBL] [Abstract][Full Text] [Related]
40. Number of tumor foci predicts prognosis in papillary thyroid cancer.
Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS
BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]